197 related articles for article (PubMed ID: 1398958)
1. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
Kim JJ; Zhou D; Mandrell RE; Griffiss JM
Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
[TBL] [Abstract][Full Text] [Related]
2. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
3.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
4. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.
Rest RF; Frangipane JV
Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573
[TBL] [Abstract][Full Text] [Related]
5. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
6. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.
Ram S; Sharma AK; Simpson SD; Gulati S; McQuillen DP; Pangburn MK; Rice PA
J Exp Med; 1998 Mar; 187(5):743-52. PubMed ID: 9480984
[TBL] [Abstract][Full Text] [Related]
7. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.
Wetzler LM; Barry K; Blake MS; Gotschlich EC
Infect Immun; 1992 Jan; 60(1):39-43. PubMed ID: 1729195
[TBL] [Abstract][Full Text] [Related]
8. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
[TBL] [Abstract][Full Text] [Related]
9. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
[TBL] [Abstract][Full Text] [Related]
11. Interaction of pathogenic Neisseria with host defenses. What happens in vivo?
Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D
Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170
[TBL] [Abstract][Full Text] [Related]
12. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens.
de la Paz H; Cooke SJ; Heckels JE
Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():913-20. PubMed ID: 7539687
[TBL] [Abstract][Full Text] [Related]
13. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.
Estabrook MM; Griffiss JM; Jarvis GA
Infect Immun; 1997 Nov; 65(11):4436-44. PubMed ID: 9353017
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin.
Gulati S; Sastry K; Jensenius JC; Rice PA; Ram S
J Immunol; 2002 Apr; 168(8):4078-86. PubMed ID: 11937567
[TBL] [Abstract][Full Text] [Related]
15. Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkC.
Schneider H; Schmidt KA; Skillman DR; Van De Verg L; Warren RL; Wylie HJ; Sadoff JC; Deal CD; Cross AS
J Infect Dis; 1996 Jun; 173(6):1422-7. PubMed ID: 8648215
[TBL] [Abstract][Full Text] [Related]
16. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H
Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
Parsons NJ; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated.
Elkins C; Carbonetti NH; Varela VA; Stirewalt D; Klapper DG; Sparling PF
Mol Microbiol; 1992 Sep; 6(18):2617-28. PubMed ID: 1280317
[TBL] [Abstract][Full Text] [Related]
20. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
